Pathological examination and IHC analysis provide conclusive evidence for diagnosis, in which the tumor’s positive response to thyroid-specific markers, such as TTF-1, PAX8, and thyroglobulin, is key to diagnosis. Here, TTF1 is linked to neoplasm.